Balance Sheet
Cash Flow Statement
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationDepreciation & Amortization (IS)Depreciation ExpenseEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

BioCorRx (BICX) Leases (2019 - 2025)

BioCorRx's Leases history spans 9 years, with the latest figure at $169443.0 for Q3 2025.

  • For Q3 2025, Leases fell 18.81% year-over-year to $169443.0; the TTM value through Sep 2025 reached $169443.0, down 18.81%, while the annual FY2024 figure was $199184.0, 104.76% up from the prior year.
  • Leases for Q3 2025 was $169443.0 at BioCorRx, down from $179555.0 in the prior quarter.
  • Across five years, Leases topped out at $464245.0 in Q1 2021 and bottomed at $70658.0 in Q1 2024.
  • The 5-year median for Leases is $218046.0 (2024), against an average of $258704.9.
  • The largest annual shift saw Leases tumbled 70.57% in 2024 before it skyrocketed 168.15% in 2025.
  • A 5-year view of Leases shows it stood at $384921.0 in 2021, then decreased by 29.75% to $270406.0 in 2022, then plummeted by 64.03% to $97278.0 in 2023, then soared by 104.76% to $199184.0 in 2024, then decreased by 14.93% to $169443.0 in 2025.
  • Per Business Quant, the three most recent readings for BICX's Leases are $169443.0 (Q3 2025), $179555.0 (Q2 2025), and $189468.0 (Q1 2025).